# Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral Therapy

> **NCT05168137** · PHASE4 · UNKNOWN · sponsor: **Mahidol University** · enrollment: 84 (estimated)

## Conditions studied

- HIV Infections
- Inflammatory Markers
- Colchicine Adverse Reaction

## Interventions

- **DRUG:** Low-dose colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05168137
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2021-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05168137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05168137, "Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05168137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*